SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011311
Filing Date
2021-05-13
Accepted
2021-05-13 16:30:35
Documents
54
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 319418
2 ex31-1.htm EX-31.1 12401
3 ex31-2.htm EX-31.2 12310
4 ex32-1.htm EX-32.1 12274
5 image_003.jpg GRAPHIC 56141
  Complete submission text file 0001493152-21-011311.txt   2059897

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pcsa-20210331.xml EX-101.INS 192314
7 XBRL SCHEMA FILE pcsa-20210331.xsd EX-101.SCH 32245
8 XBRL CALCULATION FILE pcsa-20210331_cal.xml EX-101.CAL 46566
9 XBRL DEFINITION FILE pcsa-20210331_def.xml EX-101.DEF 90126
10 XBRL LABEL FILE pcsa-20210331_lab.xml EX-101.LAB 197415
11 XBRL PRESENTATION FILE pcsa-20210331_pre.xml EX-101.PRE 156002
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39531 | Film No.: 21920108
SIC: 2834 Pharmaceutical Preparations